Picture of Century Therapeutics logo

IPSC — Century Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Century Therapeutics Reports Second Quarter 2022 Financial Results

Aug 11 (Reuters) - Century Therapeutics Inc  IPSC.O :
    * CENTURY THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
    * CENTURY THERAPEUTICS INC - ENDED Q2 2022 WITH CASH, CASH
EQUIVALENTS, AND INVESTMENTS OF $429.4; EXPECTED CASH RUNWAY
INTO 2025
    * CENTURY THERAPEUTICS INC - EXPECTS FULL YEAR GAAP
OPERATING
EXPENSES TO BE BETWEEN $155 MILLION AND $165 MILLION
    * CENTURY THERAPEUTICS INC - NET LOSS WAS $31.0 MILLION FOR
THREE
MONTHS ENDED JUNE 30, 2022, COMPARED TO $23.3 MILLION FOR SAME
PERIOD IN 2021

Source text for Eikon:  ID:nGNX9fgJLW 
Further company coverage:  IPSC.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Century Therapeutics

See all news